Singapore Clinical Trial: A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Tersolisib (LY4064809) Combined with a CDK4/6 Inhibitor and Endocrine Therapy in Adults with HR+, HER2- Advanced Breast Cancer with a PIK3CA Mutation Who Received No Prior Treatment for Advanced Breast Cancer (PIKALO-2)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 2, Randomized, Open-Label Dose Optimization and Phase 3, Randomized, Double-Blind, Placebo... Read More

Singapore Clinical Trial: A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailability of a Single Subcutaneous Dose of LY3841136 and to Evaluate the Pharmacokinetics of a Single Intravenous Dose of LY3841136 in Healthy Participants.

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 1 Open-Label Study to Determine the Effect of Injection Site on the Relative Bioavailabili... Read More

Singapore Clinical Trial: Efficacy of Yang Shen Dan in Mild to Moderate Alzheimer’s Disease: Randomised controlled study

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'Efficacy of Yang Shen Dan in Mild to Moderate Alzheimer’s Disease: Randomised controlled study'. T... Read More

Singapore Clinical Trial: A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ALK201 for Injection in Adult Participants with Advanced Solid Tumors

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A First-in-Human, Open-Label, Multi-Center Phase I/II Clinical Study to Evaluate the Safety, Toler... Read More

Singapore Clinical Trial: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Ensifentrine (MK-5884) Versus Placebo for the Prevention of COPD Exacerbations in Adults with a History of Moderate or Severe Exacerbations While Receiving Standard of Care (ENHANCE-3)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ... Read More

Clinical Trial: Virtual Reality and Point-of-View Video Modeling for Dental Anxiety in Children

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07894744) titled 'Virtual Reality and Point-of-View Video Modeling for Dental Anxiety in Children' on Oct. 19... Read More

Singapore Clinical Trial: An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of verducatib q.d. in patients with bronchiectasis (AIRTIVITY®-ON)

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'An open-label, roll-over study evaluating the long-term safety and efficacy of an oral dose of ver... Read More

Singapore Clinical Trial: A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination with Pomalidomide and Dexamethasone Versus Standard Available Therapy in Patients with Relapsed or Refractory Multiple Myeloma

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Multicenter, Open-Label, Randomized Study to Evaluate Inobrodib in Combination with Pom... Read More

Clinical Trial: Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced Glaucoma: A Prospective Interventional Study

U.S., Oct. 27 -- ClinicalTrials.gov registry received information related to the study (NCT07895537) titled 'Short-Term Efficacy and Safety of Combined Deep Sclerectomy With Trabeculotomy in Advanced ... Read More

Singapore Clinical Trial: A Long-Term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of Pulmonary Arterial Hypertension

Singapore, Oct. 27 -- The Health Sciences Authority received information related to the study titled 'A Long-Term Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder for Treatment of... Read More

• ««
• «
• 31
• 32
• 33
• 34
• 35
• 36
• 37
• 38
• 39
• 40
• »
• »»